Classification
Product TypeIngredient
Product FormExtract (powder or liquid concentrate)
Industry PositionFood Ingredient / Nutraceutical Ingredient
Market
Spirulina extract in Spain is primarily positioned as an ingredient used in food supplements and other wellness-oriented food applications within the EU single market. Spain applies EU-wide rules for food supplements and, for products marketed as supplements, requires notification/communication to the competent authorities with the product label prior to or simultaneous with first placing on the market. Market access risk is concentrated in regulatory classification: depending on composition and production process, a spirulina-derived extract may require assessment under the EU Novel Food framework before it can be marketed. Spain also has active microalgae/spirulina research and development aimed at producing industrial and nutraceutical compounds, supporting niche domestic cultivation and value-added processing alongside intra-EU and third-country sourcing.
Market RoleDomestic consumption market with niche domestic production and emerging processing, operating under EU single-market rules
Domestic RoleIngredient used mainly in food supplements (dose forms) and in formulations seeking microalgae-derived nutritional or functional compounds
Risks
Regulatory Compliance HighEU/Spain market access can be blocked if a spirulina-derived extract is deemed to require Novel Food authorisation (e.g., due to extraction/concentration or process novelty) and such authorisation is not in place, or if a finished product marketed as a food supplement in Spain is not properly notified/communicated to the competent authorities.Run a pre-market regulatory classification review (Novel Food applicability, intended use, format, claims) and complete Spain’s supplement notification/communication with label submission where applicable before launch.
Food Safety HighMicroalgae/cyanobacteria-based supplement ingredients can be contaminated with cyanotoxins (e.g., microcystins) and other contaminants (e.g., heavy metals), creating recall, rejection, and consumer safety risk if not controlled and tested.Qualify suppliers with validated contaminant controls; require COAs for each lot (microcystins where applicable, heavy metals), retain reference samples, and align testing plans to EU contaminant risk management expectations.
Labeling MediumNon-compliant labelling or marketing claims (especially disease-treatment/prevention implications) can trigger enforcement actions; Spain and the EU require food information to be accurate and not misleading, and Spain’s supplement guidance explicitly prohibits disease claims for supplements.Perform an EU/Spain label and claims review (including online listings) against Regulation (EU) No 1169/2011 and Spain’s supplement labelling guidance before placing product on the Spanish market.
Documentation Gap MediumInsufficient technical documentation (specification, contaminant COAs, traceability records, and—if relevant—Novel Food or organic documentation) can delay customs release, buyer acceptance, or Spain market notification.Use a standardized dossier: spec sheet, lot COA, traceability map, manufacturing flow summary, label files, and conditional documents (TRACES e-COI; Novel Food rationale/authorisation).
FAQ
If a spirulina-extract product is marketed as a food supplement in Spain, is notification required?Yes. In Spain, the responsible marketer must notify/communicate food supplements to the competent authorities by providing an example of the product label prior to or simultaneous with the first placing on the market.
What is the biggest regulatory “stop” risk for spirulina-extract in Spain?Novel Food status. If the extract (due to its composition or production process) is considered a Novel Food under EU rules and is not authorised, it cannot be legally placed on the EU market, including Spain.
What food-safety hazards are most important to control for microalgae/cyanobacteria-based supplement ingredients like spirulina extracts?Contaminants are a key risk area. Scientific literature and regulator guidance highlight that cyanotoxins such as microcystins can occur in algal dietary supplement products, and EU food-safety rules also focus on limiting chemical contaminants such as heavy metals in foods.